Clinical Trial

Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil. However, following Remifentanil treatment an increased sensitivity to pain \[hyperalgesia\] appears. The aim of the study is to compare the effects between complementary treatments, like Ketalar and Dexmedetomidine, in preventing increased sensitivity to pain after Remifentanil treatment
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-19.
Trial Details
NCT Number NCT06473896
Lead Sponsor Assaf-Harofeh Medical Center
Conditions Cholecystectomy
Enrollment 90 participants
Start Date 2024-04-18
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-07